Galileo Galilei
PI: Nathan Shock Center of Excellence in the Biology of Aging
PI: Glenn Center for the Biology of Human Aging.
Co-Scientific Director of the American Federation for Aging Research
Founder and on the Board of CohBar Inc.
Chief Medical Advisor for Life Bioscience
Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging and the principal investigator of the Einstein Nathan Shock Center and the Glenn center. He was the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies.
He is the author of over 270 peer-reviewed papers and a recipient of numerous prestigious awards, including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions.
Dr. Barzilai is on the board of AFAR, its scientific director and a founding member of the Academy for Lifespan and Health span. He co-founded CohBar and Lifebioscinces. He has been featured in major papers, TV program and documentaries (2 TEDx and TEDMED) and has been consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, Prime Minister office in Israel, several International Banks, The Vatican, Pepsico, Milken Institute, Davos Economical Forum, and featured in The Wall Street Journal, New York Times, The Economist and Wired Magazine. His book Age Later was published in the June of 2020.
Dr. Kaushik, as assistant professor of chemistry at the Department of Environmental Engineering of Florida Polytechnic University, is exploring advanced functional chemistries, nano-biotechnology, electrochemical biosensors, nanomedicine, and biomedical engineering for intelligent health wellness.
He is the recipient of various reputed awards for his significant contribution in the research field of nano-biotechnology for health care. Dr. Kaushik is scholarly accomplished as reflected by edited books, international peer-reviewed publications, and patents in nanomedicine and smart biosensors for personalized health care. For more than 10 years, Dr. Kaushik is an active mentor, supervisor, and helping various federal and private organizations as a fellow, consultant, and review board member.
During his research, Dr. Kaushik is actively involved in exploring tunable high-performance performance sensing systems for point-of-care application and nanomedicine for personalized therapy. To achieve his goal of intelligent personalized health wellness, Dr. Kaushik works in collaboration and seeks more globally.
Dr. Ronjon Nag is an inventor and entrepreneur. He is a founder and advisor/board member of multiple start-ups. His companies have been sold to Apple, BlackBerry, and Motorola. He has been awarded the Mountbatten Medal in the Royal Institution by the Institution of Engineering and Technology and has been the winner (Bounce Imaging-Board) of the $1m Verizon Powerful Answers Award. He has been a pioneer of smartphones and the 'app stores' they depend on.
He has worked on neural networks, touch screens, mobile search, voice recognition, text prediction, and handwriting recognition. He has a Ph.D. from Cambridge, an M.S from M.I.T, and a B.Sc. from Birmingham in the UK. Additionally, he is a Stanford Distinguished Careers Institute Interdisciplinary Fellow based at the Stanford Center for Language and Information (CSLI).
Professor de Magalhaes graduated in Microbiology in 1999 from the Escola Superior de Biotecnologia in his hometown of Porto, Portugal, and then obtained his Ph.D. in 2004 from the University of Namur in Belgium. Following a postdoc with genomics pioneer Prof George Church at Harvard Medical School, in 2008 Prof de Magalhaes was recruited to the University of Liverpool. He now leads the Integrative Genomics of Ageing Group which focuses on understanding the genetic, cellular, and molecular mechanisms of aging. Professor de Magalhaes has authored over 100 publications and given over 100 invited talks, including three TEDx talks. He is also Chief Scientific Officer of Swiss-based biotech Centaura. His ultimate goal is to develop interventions that preserve health and fend off age-related diseases by manipulating the aging process.
Collin has a longstanding interest in the molecular biology of healthy aging and age-related pathologies.
He is the founder and currently the president of the Swiss Society for Aging Research (www.ssfar.ch). He has received multiple awards, including NYAS Future Entrepreneur recognized by the New York Academy of Sciences, and is named under the top 1000 Longevity Leaders worldwide and the top 15 Longevity Influencers in Switzerland.
Research interests: Our recent work has shown that many health- and longevity-promoting interventions re-activate the expression of extracellular matrix (ECM) genes during aging (Ewald et al., Nature 2015, PMID:25517099). This ECM enhancement is required and sufficient for extending the lifespan of C. elegans. Our research efforts are focusing on exploring the mechanism(s) of how prolonged ECM homeostasis promotes healthy aging.
Expertise: C. elegans ECM, aging, protein aggregation, neurodegeneration (Alzheimer's disease), Insulin/IGF-1 signaling, NADPH oxidases, ROS, oxidative stress, automated lifespan assessment, genetic and chemical high-throughput screening.
Lab website: http://ewaldlab.com
Twitter: @CollinEwald
Ravi Bala is an AgeTech Evangelist and a startup mentor in AgeTech and Remote Monitoring. He is a Co-Founder and former Board Member at HealthSignals, LLC, a leader in technology solutions for better senior living. An innovator and an expert in mobile health and digital strategy, he has a successful track record of creating and managing teams of independent thinkers. He has a tenacious dedication to compassion and dignity in the workplace. He is a teacher, a mentor, and a coach at heart and works with many startup ventures as an advisor.
He is currently Chair of the Capital for Good and board member for Girls First Fund – a global effort to end child marriage and is on the Advisory Board of CyberSeniors and the SeniorTrade Blog. He is also a mentor with the Silver Moonshots accelerator and a member of the Drexel University AgeWell Collaboratory. He has taught courses in Digital Strategy in multiple MBA programs in Philadelphia. His latest passion is changing the model of eldercare with the aid of Conversational AI, Robotics and Passive Monitoring.
Ms. Maha Abuyabis has passionately spent 9 years supporting Saudi biotech entrepreneurs to create ventures. She worked in business development at Badir Biotechnology Incubator (Badirbio) is one of the initiatives of King Abdulaziz City of Science and technology. Badirbio is one of the 1st incubators supporting biotech business in the kingdom of Saudi Arabia & During this time she supported a wide variety of biotechnology companies such as digital healthcare, molecular biology, and some startups with patented innovations from the ideation stage till the growth stage such as the stability laboratory service, Noawin (patient taxi application) & VOXEL( medical 3d printing technology).
While she was working, she completed her Master's degree in business administration from Dublin City University in Riyadh and spent 8 years of her life in India to pursue her education from high school till she earned her Bachelor's degree in Biotechnology from Bangalore University. Throughout her career path and experience in the local biotech industry, Maha moved to the private sector and worked in business development from sales and relationship manager and assessing new business opportunities. Lastly, Maha worked as a business development manager at a Research product and development company(RPDC) one of the subsidiaries of TAQNIA specialized in technology commercialization focusing on the pharmaceutical industry and Artificial intelligence and work closely with academic and R&D institutions to commercialize the potential outputs of their research and provide technology assessments.
Raju has over 25 years of experience as a software professional in various roles from developer to architect. Currently, he is working on building bioinformatics software in the cloud that is easy to use and scalable.
Raju is nterested in innovating in the life sciences space to advance human health.
Completing his Bachelors of Science and Medical degrees from University College Medical School in London his passion for extreme physiology has allowed him to conduct field research across the planet. With expeditions taking him to the sides of Everest, skiing in the Arctic and the European Alps, he has served as a medical officer in the Royal Air Force and at NASA’s Kennedy Space Center. After practicing clinical medicine in London, in 2010, he made the transition to Mumbai where he has worked within the Healthcare and Life-sciences industry as a Strategic advisor, Investor and Operator for a range of MNC and national bellwether firms.
Augmenting his contributions towards global health commentary, the Covid-19 pandemic has brought Marcus back to the frontlines of medicine as a medical volunteer for his city’s fight against controlling the virus. A published author, keynote speaker, digital talk show host and public health commentator, he has been a World Economic Forum’s Global Shaper and is currently a Senior Fellow to the Atlantic Council, working on a project exploring the relationships between the climate crisis and global health. A champion of wellbeing, Marcus is a big believer that sustainably improving the lives of billions of people the world over can only be brought about by enhancing the positive aspects of health rather than focusing solely on pathogenesis and disease.
Marcus is a keen athlete and long distance marathon runner, he holds a Guinness World Record for backwards running and thoroughly enjoys being a father to his two young children.
At Shift Bioscience, Daniel is making safer drugs for cellular rejuvenation in humans by applying machine-learning 'driver' clocks to cellular reprogramming. Daniel is also a founding fellow of the OnDeck Longevity Biotech fellowship.
At U. Cambridge, Daniel used a computationally guided screen to identify molecules that eliminate mitochondrial DNA mutations. Daniel later founded Shift Bioscience, quickly embracing aging clocks, and guided Brendan Swain (CSO) to develop an accurate single cell aging clock using gene expression data.
This clock enabled a CRISPR screen for ageing, and excitingly, many clock genes were known 'drivers' of ageing phenotypes. The driver-clock methodology was applied to cell-reprogramming to identify putative drug targets for safe cellular rejuvenation and Daniel is now racing to validate these targets.
- Digital Health and EHealth platform development
- Setting up structures for Translational and Entrepreneurial Medicine and business modelling in private-public partnerships
- Implementation of Swiss Health Policy for Highly Specialized Medicine
- Constructing, reorganizing, and merging of hospitals
- Knowledge management and postgraduate training
https://www.linkedin.com/in/slamah/
He has acquired a PhD in Physics and Nanotechnology from the Technical University of Denmark and Masters from University of Glasgow. During his PhD, he was handpicked as a Kauffman Global Scholar to embark on a 6 month intensive entrepreneurial training fellowship coordinated by the Kauffman Foundation in collaboration with MIT, Stanford University and Harvard University. He is recipient of numerous research and innovation awards including Outstanding Research-Driven Innovation award from National Research Foundation of Luxembourg.
He is the founder of Chiaro, of communications agency for Health & Life Sciences companies preparing for fundraising. His clients went on to raise millions of euros, close high-value deals, and take their business to the next level.
A former scientist-turned-communication pro, Giuseppe has worked with some of the most admired organizations of the sector, from academia and biotech to big pharma. Giuseppe is also pitch coach for Europe’s leading start up accelerators.
And in case you’re wondering, 'Chiaro' is Italian for clear and brilliant.
Cumulative experience of 12 years in Healthcare & Life sciences
· Healthcare innovations: Biotech, Digital Health, MedTech, Wellness
· Portfolio management & strategy
· Building partnerships and strategic initiatives
· Business and domain consultancy
Pritam has published more than 40 papers including many in top ranked journals, such as Nature Medicine, Science Advances, Nature Leukemia, Materials Today, Inorganic Chemistry (ACS), Adv. Functional Materials (Wiley) etc. and also serves as referee for various reputed journals. His expertise includes drug designing and discovery, immunoinformatics, molecular modeling, oncology, molecular dynamics, 2D-materials modeling, nano-biotechnology, biophysics, computational materials science and nanomedicine.
His transition into Biotech, inspired by medical challenges, was in building and scaling ventures to target pain management with non-opioids and pathogens including SARS-CoV-2 with nanobodies and small molecules. His work was nominated at World Economic Forum COVID-19 Response Challenge in 2020, following his research in Pandemics in 2007. Currently, his venture Lagrangian is scaling Kondor Pharma a Canadian Biotech building nutraceutical and RX products to target inflammation.
He launched Neurometry, where the team is unifying Biomedical Engineering and Neurology to design tools for a Telemedicine Platform with Gamification to diagnose and manage patients with neurological and neuro cognitive disorders.
He obtained a M.Sc. (2013) in Quantitative Finance from London Business School, and BA (Hon) from University of Toronto in Economics, Statistics and Theology.
Karolina Mackiewicz (MA Political Sciences, MA Futures Studies) has over 12 years of professional experience in international research and innovation cooperation for health and wellbeing.
She worked for the WHO European Healthy Cities network, leading the WHO Collaborating Centre for Healthy Cities and Urban Health in the Baltic Sea Region, and the Development Manager at MyData Global – an international non-for-profit advocating for a human-centric approach to personal data. When it comes to digital health, as a head of innovation unit of European Connected Health Alliance, she is especially interested in how technology and data can support the sustainable health systems of tomorrow, health literacy and socio-economic determinants of health.
Karolina will support the hackathon teams with her experience and expertise on: health systems, human-centric design, user-requirements for digital technologies, ethical use of personal data for health and wellbeing, and morbidity and ageing.
